Jay Berzofsky | Branch Chief, Vaccine Branch
National Cancer Institute - NIH

Jay Berzofsky, Branch Chief, Vaccine Branch, National Cancer Institute - NIH

Dr. Jay A. Berzofsky was appointed Chief, Vaccine Branch, Center for Cancer Research, National Cancer Institute, in 2003, after being Chief, Molecular Immunogenetics and Vaccine Research Section, since 1987. He graduated Summa cum Laude from Harvard (1967), and received a PhD-MD from Albert Einstein College of Medicine (AECOM). After interning at Massachusetts General Hospital, he joined NIH in 1974. Dr. Berzofsky's research has focused on antigen processing/presentation, epitope structure, cytokine and regulatory cell control of T cell function and avidity, NKT cells, and translation to the design and clinical trials of vaccines for AIDS, cancer, and viruses causing cancer. He has 545 scientific publications. He was elected President of the American Society for Clinical Investigation (1993-94), a member of the Association of American Physicians, a Fellow of the American Association for the Advancement of Science (AAAS), and Distinguished Alumnus of the Year for 2007 by AECOM. He was elected Chair of the Medical Sciences Section of the AAAS for 2007-2008. He received the NIH Director’s Award and the NCI Merit Award in 2008, another NCI Director’s Merit Award in 2011 and one in 2020, and a Career Award “for his important contribution to tumor immunotherapy” from the European Academy of Tumor Immunology in 2018. In addition to the above, Jay was formerly the past-president of the ASCI (American Society for Clinical Investigation).


Day 3 - Thursday 4th April @ 09:10

Combinations of vaccines with novel immunomodulatory agents beyond checkpoint inhibitors

last published: 30/Nov/23 11:25 GMT

back to speakers